| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Revenues: | |||||||||
Service revenues | |||||||||
- | - | - | - | - | - | - | - | 63 | - |
Product revenues | |||||||||
- | - | - | 5,600 | 4,416 | 3,378 | 2,914 | 1,170 | 1,154 | 69 |
Development service revenues | |||||||||
- | - | - | - | 37 | 103 | 283 | 541 | - | - |
Service and other revenues | |||||||||
- | - | - | 149 | 140 | 121 | 82 | - | - | - |
Related party license revenues | |||||||||
- | - | - | - | - | - | 650 | 3,346 | 2,600 | 2,600 |
Total revenues | |||||||||
11,216 | 7,353 | 7,379 | 5,749 | 4,594 | 3,604 | 3,930 | 5,058 | 3,818 | 2,669 |
Cost of revenues | |||||||||
3,832 | 2,433 | 2,898 | - | - | - | - | - | - | - |
Cost of revenues | |||||||||
- | - | - | 2,642 | 1,987 | 1,927 | 1,421 | 555 | 656 | 16 |
Research and development costs | |||||||||
2,922 | 2,310 | 2,813 | 2,628 | 1,957 | 3,297 | 2,922 | 2,484 | 4,251 | 5,681 |
Sales and marketing expenses | |||||||||
4,755 | 3,532 | 3,956 | 3,777 | - | - | - | - | - | - |
Reversal of research and development obligation | |||||||||
- | - | - | - | - | - | - | 882 | - | - |
General and administrative expenses | |||||||||
4,299 | 4,325 | 4,046 | 4,190 | 8,370 | 8,039 | 7,061 | 6,029 | 4,831 | 4,698 |
Restructuring charges | |||||||||
- | - | - | - | 1,252 | 0 | - | - | - | - |
Gain on sale of intellectual property | |||||||||
- | - | - | - | - | 4,338 | - | - | - | - |
Costs of withdrawn IPO | |||||||||
- | - | - | - | - | - | - | - | - | 1,788 |
Total costs and operating expenses | |||||||||
- | - | - | - | - | - | - | 8,187 | 9,739 | 12,184 |
Operating loss | |||||||||
-4,593 | -5,247 | -6,335 | -7,488 | -8,974 | -5,320 | -7,474 | -3,129 | -5,921 | -9,515 |
Other income (expense): | |||||||||
Gain on change in fair value of derivative liabilities | |||||||||
- | 64 | 24 | 1,065 | 1,539 | 1,549 | 1,686 | -171 | - | - |
Loss on debt restructuring | |||||||||
- | - | - | -811 | 0 | - | - | - | - | - |
Gain on forgiveness of amounts in accounts payable | |||||||||
- | - | - | - | - | 77 | - | - | - | - |
Gain on forgiveness of amounts in accounts payable | |||||||||
- | - | - | - | - | - | 477 | - | - | - |
Loss on note payable modification | |||||||||
- | - | - | - | - | - | 1,356 | - | - | - |
Gain (loss) on change in fair value of derivative liability | |||||||||
- | - | - | - | - | - | - | - | - | 1,227 |
Other income (expense), net | |||||||||
9 | 0 | 16 | 216 | 230 | 175 | 56 | 3 | 104 | 413 |
Interest income | |||||||||
- | - | - | - | 16 | 11 | 24 | 14 | 3 | 10 |
Interest expense, net | |||||||||
955 | 980 | 872 | 1,051 | 1,262 | 1,018 | 499 | 2,594 | 2,498 | 1,590 |
Net loss | |||||||||
-5,539 | -6,163 | -7,167 | -8,069 | -8,449 | -4,524 | -7,086 | -5,877 | -8,311 | -9,454 |
Net loss per share attributable to common stockholders: | |||||||||
Basic and diluted (in dollars per share) | |||||||||
-0.42 | -0.56 | -0.93 | -2.93 | -4.48 | -0.08 | -0.12 | -0.15 | -0.52 | -1.40 |
Weighted average shares outstanding: | |||||||||
Basic and diluted (in shares) | |||||||||
13,155 | 10,928 | 7,738 | 2,754 | 1,884 | 59,240 | 57,261 | 40,374 | 15,961 | 6,773 |
Product Revenue | |||||||||
Total revenues | |||||||||
9,476 | 6,685 | 7,024 | - | - | - | - | - | - | - |
Service and Other Revenues | |||||||||
Total revenues | |||||||||
1,740 | 668 | 355 | - | - | - | - | - | - | - |